Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Catherine H. Han"'
Autor:
Catherine H. Han, Prashannata Khwaounjoo, Andrew G. Hill, Gordon M. Miskelly, Mark J. McKeage
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract This study evaluated the impact of calcium and magnesium on the in vitro degradation and in vivo clearance of oxaliplatin. Intact oxaliplatin and Pt(DACH)Cl2 were measured in incubation solutions by HPLC-UV. A clinical study determined chang
Externí odkaz:
https://doaj.org/article/4d56bc64c892498384d45ce82fe2a83d
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal non-Hodgkin lymphoma (NHL), confined to the brain, eyes, spinal cord or leptomeninges without systemic involvement. Overall prognosis, diagnosis and management of PCN
Externí odkaz:
https://doaj.org/article/8734ce3fc39c4c2ebb62c6b8612c6679
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
In the current era of molecularly targeted therapies and precision medicine, choice of cancer treatment has been increasingly tailored according to the molecular or genomic characterization of the cancer the individual has. Previously, the clinical o
Externí odkaz:
https://doaj.org/article/63ed03f384e5436da5ccd35597e7d548
Autor:
Harry C. Alexander, Cindy H. Nguyen, Michael J.J. Chu, Gregory P. Tarr, Catherine H. Han, Robert H. Thomas, Andrew H. Holden, Adam S.J.R. Bartlett
Publikováno v:
Journal of Vascular and Interventional Radiology. 33:1559-1569.e2
To assess the safety and effectiveness of transarterial radioembolization (TARE) in the treatment of hepatic metastases from pancreatic ductal adenocarcinoma (PDAC).A systematic search of the Embase and MEDLINE databases was conducted using keywords
Autor:
Ikumi Tamai, Khine Myint, Yan Li, Fabrice Merien, Catherine H. Han, Johnson J. Liu, Mark J. McKeage, Stephen M. F. Jamieson, Takeo Nakanishi, Jun Lu, Nancy N. Jong, Christopher J. Squire, Riya Biswas
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Scientific Reports
Oxaliplatin is important for the clinical treatment of colorectal cancer and other gastrointestinal malignancies, but tumour resistance is limiting. Several oxaliplatin transporters were previously identified but their relative contributions to deter
Autor:
Tracy T. Batchelor, Catherine H. Han
Publikováno v:
CONTINUUM: Lifelong Learning in Neurology. 23:1601-1618
Primary central nervous system (CNS) lymphoma is a rare and aggressive extranodal non-Hodgkin lymphoma confined to the brain, eyes, spinal cord, or leptomeninges without systemic involvement. This article provides an overview of the clinical features
Autor:
Catherine H. Han, Tracy T. Batchelor
Publikováno v:
Cancer. 123:4314-4324
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal non-Hodgkin lymphoma (NHL) that is confined to the brain, eyes, spinal cord, or leptomeninges without systemic involvement. The overall prognosis, diagnosis, and mana
Publikováno v:
Clinical Neurophysiology. 131:343-344
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 12:1479-1490
Oxaliplatin-based chemotherapy has become the standard treatment for colorectal cancer and other gastrointestinal tumor types. Oxaliplatin-induced neurotoxicity is a major treatment-limiting side effect that compromizes the delivery of cancer treatme
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal non-Hodgkin lymphoma (NHL), confined to the brain, eyes, spinal cord or leptomeninges without systemic involvement. Overall prognosis, diagnosis and management of PCN